CTKB

Cytek Biosciences, Inc.
$4.01
+0.05 (+1.26%)
Mkt Cap 517.86M
Volume 836,369
52W Range 2.43-6.18
Sector Healthcare
Beta 1.23
EPS (TTM) -0.58
P/E Ratio -9.70
Revenue (TTM) 204.17M
Rev Growth (5Y) +16.8%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
$1.48
Overvalued · Strong
170.6% above fair value
AlphaQuality · Grade · Gated
F
Stable Earnings Power
28.1 / 100 pillar composite (overridden)

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue 201.49M 200.45M 193.01M 164.04M 127.95M 92.84M 57.88M
Net Income (66.54M) (6.02M) (12.15M) 2.58M 3.00M 19.41M (16.83M)
EPS -0.52 -0.05 -0.09 0.02 0.03 0.02 -0.13
Free Cash Flow (8.77M) 21.85M 454,000 (22.10M) 266,000 13.61M (14.72M)
FCF / Share -0.07 0.17 0.00 -0.16 0.00 0.10 -0.11
Operating CF (4.69M) 25.38M 5.28M (12.23M) 4.63M 15.16M (13.75M)
Total Assets 461.54M 499.50M 494.46M 519.48M 463.31M 219.98M 70.36M
Total Debt 23.74M 17.02M 14.14M 18.09M 0 2.77M 0
Cash & Equiv 90.85M 98.72M 167.30M 296.60M 364.62M 165.23M 30.12M
Book Value 341.74M 395.74M 393.06M 425.30M 405.04M (16.03M) (41.70M)
Return on Equity -0.19 -0.02 -0.03 0.01 0.01 N/A N/A
CTKB News
Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript
May 07, 2026 06:01 PM · seekingalpha.com
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates
May 07, 2026 04:11 PM · zacks.com
Cytek Biosciences Reports First Quarter 2026 Financial Results
May 07, 2026 12:05 PM · globenewswire.com
Analysts Set Cytek Biosciences, Inc. (NASDAQ:CTKB) PT at $5.38
Apr 23, 2026 11:46 PM · defenseworld.net
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 23, 2026 12:05 PM · globenewswire.com
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
Mar 09, 2026 01:00 PM · globenewswire.com
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference
Mar 08, 2026 10:05 PM · defenseworld.net
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
Feb 26, 2026 04:06 PM · zacks.com
Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript
Feb 26, 2026 03:57 PM · seekingalpha.com
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook
Feb 26, 2026 11:05 AM · globenewswire.com